FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for lanthanum carbonate (Cipla USA Inc.). This action updates the product's regulatory approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

SUPPL AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)